These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


519 related items for PubMed ID: 17138485

  • 21. Impact of an antidepressant management program on medication adherence.
    Hoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C.
    Am J Manag Care; 2003 Jan; 9(1):70-80. PubMed ID: 12549816
    [Abstract] [Full Text] [Related]

  • 22. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 23. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B, Shaffer TJ, Simoni-Wastila LJ, Zuckerman IH, Quinn CC.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [Abstract] [Full Text] [Related]

  • 24. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C, Barner JC, Lawson KA, Johnsrud MT.
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [Abstract] [Full Text] [Related]

  • 25. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO, Barner JC, Rascati KL, Strassels SA.
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [Abstract] [Full Text] [Related]

  • 26. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C, Becker RV, Mucha L, Lorenz BH, Eaddy MT, Ogbonnaya AO.
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [Abstract] [Full Text] [Related]

  • 27. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
    Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC.
    Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care.
    Maidment R, Livingston G, Katona C.
    Int J Geriatr Psychiatry; 2002 Aug; 17(8):752-7. PubMed ID: 12211126
    [Abstract] [Full Text] [Related]

  • 30. Adherence to continuation and maintenance antidepressant use in recurrent depression.
    ten Doesschate MC, Bockting CL, Schene AH.
    J Affect Disord; 2009 May; 115(1-2):167-70. PubMed ID: 18760488
    [Abstract] [Full Text] [Related]

  • 31. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
    Kalsekar I, Sheehan C, Peak A.
    Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
    [Abstract] [Full Text] [Related]

  • 32. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D, Lee WC, Balu S, Joshi AV, Pashos CL.
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [Abstract] [Full Text] [Related]

  • 33. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A.
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [Abstract] [Full Text] [Related]

  • 34. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 35. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW.
    J Manag Care Pharm; 2006 Jun; 12(1):43-54. PubMed ID: 16420107
    [Abstract] [Full Text] [Related]

  • 36. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
    Nau DP, Mallya U.
    Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854
    [Abstract] [Full Text] [Related]

  • 37. Effects of primary care depression treatment on minority patients' clinical status and employment.
    Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells K.
    Arch Gen Psychiatry; 2004 Aug; 61(8):827-34. PubMed ID: 15289281
    [Abstract] [Full Text] [Related]

  • 38. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 39. Clinician awareness of adherence to hypertension guidelines.
    Steinman MA, Fischer MA, Shlipak MG, Bosworth HB, Oddone EZ, Hoffman BB, Goldstein MK.
    Am J Med; 2004 Nov 15; 117(10):747-54. PubMed ID: 15541324
    [Abstract] [Full Text] [Related]

  • 40. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M, Moride Y, Crott R, du Fort GG, Ducruet T.
    J Affect Disord; 2009 May 15; 115(1-2):160-6. PubMed ID: 18694602
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.